To evaluate the lesion detectability of the Wavelia #2 Microwave Breast Imaging System in a clinical setting, with implications for improving breast cancer diagnosis.
Key Findings:
Lesions were detected in 56 out of 62 patients, yielding a sensitivity of 90% (95% c.i.: 80.5 to 95.5).
High sensitivity was maintained across various lesion subtypes and in young, pre-menopausal women with dense breasts.
All lesions ≤15 mm were accurately detected.
Interpretation:
Wavelia shows promise as an adjunct or alternative to current breast imaging modalities, particularly for high-risk populations with dense breast tissue, highlighting its potential impact on clinical practice.
Limitations:
The study was limited by a modest single-centre sample size, which may affect generalizability.
A high proportion of lesions marked with biopsy clips may have influenced detectability, introducing potential bias.
Conclusion:
Wavelia's high performance in detecting lesions in challenging cohorts suggests its potential to enhance breast cancer screening and diagnostics, warranting further multicentre trials to validate these findings.
by Eoin P Kerin, John P M O’Donnell, Sami M Abd Elwahab, Thomas O Butler, Luis Bouz Mkabaah, Angie Fasoula, Giannis Papatrechas, Petros Arvanitis, Luc Duchesne, Michael K Barry, Aoife J Lowery, Michael J Kerin
